Pfizer's Trading Volume Hits 10.66 Billion, Ranks 92nd Amid Eliquis Discount and Penicillin Shortage

On July 23, 2025, Pfizer's trading volume reached 10.66 billion, ranking 92nd in the day's stock market. Pfizer's stock price increased by 0.88%, marking two consecutive days of gains, with a total increase of 4.53% over the past two days.

Pfizer, in collaboration with Bristol Myers Squibb, has announced a significant initiative to offer their blockbuster blood thinner Eliquis at a 40% discount directly to patients. This move aims to bypass traditional middlemen, potentially reducing costs for patients and enhancing market access for the drug.

Additionally, Pfizer has issued a warning regarding a near-term stock out of a penicillin product used to treat syphilis in pregnant women, following a recent recall. This development could impact the company's supply chain and patient access to critical medications.